HOME-PE Trial Clarifies Which PE Patients to Treat at Home HOME-PE Trial Clarifies Which PE Patients to Treat at Home
The randomized HOME-PE trial clarifies a transatlantic controversy regarding how best to triage patients with acute pulmonary embolism for outpatient care. Hestia criteria proved as safe as sPESI score.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 1, 2020 Category: Internal Medicine Tags: Cardiology News Source Type: news

Hospitalized COVID-19 Patients and Venous Thromboembolism Hospitalized COVID-19 Patients and Venous Thromboembolism
Early reports indicate that a very high proportion of critically ill patients hospitalized with COVID-19 will experience venous thromboembolism, particularly pulmonary embolism.Circulation (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - August 28, 2020 Category: Radiology Tags: Infectious Diseases Journal Article Source Type: news

Finer Risk Stratification Key in Acute Pulmonary Embolism Finer Risk Stratification Key in Acute Pulmonary Embolism
Patients with intermediate- to low-risk PE, and those with low-risk PE, require anticoagulation only. In contrast, patients with intermediate- to high-risk PE are at increased risk of decompensation.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 19, 2020 Category: Internal Medicine Tags: Hospital Medicine News Source Type: news

Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis
In this study, we used three thrombotic mice models to confirm the antithrombotic property of embelin. By combining the anti-inflammatory and the antithrombotic properties, we proposed embelin as a potent therapeutic agent for sepsis-induced DIC, which involves both inflammation and thrombosis. In a lipopolysaccharides-induced septic mice model, embelin not only significantly ameliorated the inflammation levels, but also effectively reduced the pulmonary hemorrhages and the micro-thrombi formations in lung. In contrast, low-molecular-weight-heparin, an anticoagulant, only moderately ameliorated the pulmonary hemorrhages an...
Source: Current Awareness Service for Health (CASH) - August 5, 2020 Category: Consumer Health News Source Type: news

What Are Some Pediatric Oncological Emergencies?
Discussion Pediatric cancers in the US number about 12,000 per year. After injury, it is the second leading cause of death in children and adolescents. Cancer presentations vary widely, but often begin with non-specific symptoms that continue or progress depending on the location and tumor type. Patients can present with oncological emergencies especially if there are mechanical obstruction such as superior vena cava syndrome or cerebral herniation. More commonly are infections due to immunosuppression. Cancer treatment also causes its own myriad of problems that clinicians need to be aware of to diagnosis and treat, but a...
Source: PediatricEducation.org - July 20, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Alembic Pharma gets tentative USFDA nod for generic Rivaroxaban tablets
Rivaroxaban tablets are indicated for multiple conditions, including reduction of risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; treatment of deep vein thrombosis (DVT) and treatment of pulmonary embolism (PE). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2020 Category: Pharmaceuticals Source Type: news

Barriers exist to using risk stratification tools to evaluate pulmonary embolism in the ED
(Society for Academic Emergency Medicine) Common barriers exist to the use of risk stratification tools in the evaluation of pulmonary embolism in the emergency department and provide insight into where to focus efforts for future implementation endeavors. That is the conclusion of a study to be published in the June 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2020 Category: International Medicine & Public Health Source Type: news

DoD Funds Clinical Trial of Seraph Blood Filter to Treat COVID-19
The Department of Defense is funding a clinical trial of a COVID-19 treatment using ExThera Medical’s Seraph 100 Blood filter. The device was selected to be in the multi-center randomized clinical trial because it showed encouraging preliminary results in critically ill COVID-19 patients at a military hospital in the U.S. and 14 other hospitals in Europe. Investigators at the Uniformed Services University in Bethesda will run the trial of the Martinez, CA-based company’s device. Initial reports indicate Seraph 100 stabilizes blood pressure and inflammatory biomarkers that correlate with ...
Source: MDDI - June 10, 2020 Category: Medical Devices Authors: Omar Ford Tags: COVID-19 Business Source Type: news

Devices Will Play A Greater Role in COVID-19
Up until now, medical devices have been in the background when it comes to the novel coronavirus. The bigger stories in the industry came from diagnostic firms either developing virus detection or antibody tests.   However, that all changed when Danvers, MA-based Abiomed was granted Emergency Use Authorization for the Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism.   I give my take on why this lone EUA could be the start of more device-related solutions regarding symptoms associated with COVID-19.   &Acir...
Source: MDDI - June 8, 2020 Category: Medical Devices Tags: COVID-19 Source Type: news

Abiomed Granted IDE to Evaluate ‘World’s Smallest Heart Pump’
Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - June 6, 2020 Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news

Thrombosis in COVID-19: clinical outcomes, biochemical and pathological changes, and treatments, CEBM
Reports that COVID-19 is associated with venous and arterial thrombosis and pulmonary embolism and increased rates of thrombosis in cannulae and extracorporeal circuits for renal replacement or membrane oxygenation, have drawn attention to the coagulant effects of the disease. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Pulmonary embolism and COVID-19
(Henry Ford Health System) Researchers at Henry Ford Health System in Detroit say early diagnosis of a life-threatening blood clot in the lungs led to swifter treatment intervention in COVID-19 patients. In a new study published recently in the journal Radiology, researchers found that 51 percent of patients found to have a pulmonary embolism, or PE, were diagnosed in the Emergency Department, the entry point for patients being admitted to the hospital. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 2, 2020 Category: Infectious Diseases Source Type: news

New EUA Places Abiomed Firmly in the COVID-19 Conversation
Sometimes when the discussion of tackling the novel coronavirus comes up, the use of medical devices gets lost in the shuffle. Most of the conversation surrounding COVID-19 comes from either the promise of a vaccine or the expansion of tests. Abiomed is adding to the conversation surrounding medtech’s potential contribution to the treatment of COVID-19 patients. Monday, the Danvers, MA-based company by receiving Emergency Use Authorization for a device to treat COVID-19 related right heart failure patients. The Impella RP is a temporary heart pump that provides circulatory support for patients who develop...
Source: MDDI - June 2, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular COVID-19 Source Type: news

FDA Issues Emergency Use Authorization for Impella RP in COVID-19 FDA Issues Emergency Use Authorization for Impella RP in COVID-19
The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 1, 2020 Category: Cardiology Tags: Cardiology News Alert Source Type: news

Odds of Pulmonary Embolism Up for Obese COVID - 19 Patients
Odds of developing PE lower for COVID - 19 patients taking statin therapy prior to admission (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 20, 2020 Category: Respiratory Medicine Tags: Infections, Pulmonology, Radiology, Critical Care, Emergency Medicine, Journal, Source Type: news

Obesity Ups Odds for Lung Clots in COVID Patients
Researchers said that obese patients with COVID-19 may have nearly three times the risk of developing what is known as a pulmonary embolism. (Source: WebMD Health)
Source: WebMD Health - May 20, 2020 Category: Consumer Health News Source Type: news

Odds of Pulmonary Embolism Up for Obese COVID-19 Patients
WEDNESDAY, May 20, 2020 -- Patients with COVID-19 with a body mass index (BMI)>30 kg/m² have increased odds of developing pulmonary embolism (PE), according to a research letter published online May 14 in Radiology. Neo Poyiadi, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2020 Category: Pharmaceuticals Source Type: news

Could COVID-19 Finally Destigmatize Mental Illness?
There is a research model going around that suggests as many as 150,000 additional people could die from mental health-related outcomes of COVID-19. I could argue the merits of the mathematical model as many of my colleagues have. I could also make the case that discussing the depths of despair and predicting increasing suicide rates over and over could, in fact, lead to copycat suicides. But what if I took an alternative stance, and told you that—though absolutely no one would wish a pandemic on anyone— this is actually what mental health needed to stop being stigmatized and start being valued? I’m not ...
Source: TIME: Health - May 13, 2020 Category: Consumer Health News Authors: Jessica Gold Tags: Uncategorized COVID-19 Source Type: news

High Rate of Pulmonary Embolism Found for Patients With COVID - 19
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D - dimer level> 2,660 µ g/L (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 28, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pulmonology, Radiology, Journal, Source Type: news

High Rate of Pulmonary Embolism Found for Patients With COVID-19
TUESDAY, April 28, 2020 -- COVID-19 is associated with a high rate of pulmonary embolism, according to two research letters published online April 23 in Radiology. Ian Leonard-Lorant, M.D., from the Nouvel Hôpital Civil in Strasbourg, France,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 28, 2020 Category: Pharmaceuticals Source Type: news

Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefi...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news

10 Years Later, Obamacare ’s Complicated Legacy Still Shapes the Nation
Maurine Stuart credits the Affordable Care Act (ACA) for saving her family. In 2014, Stuart was diagnosed with HELLP syndrome, a rare disease that causes heart, liver and lymphatic problems. As a result, she was unable to continue working full time—which meant losing her employer-sponsored health insurance. But thankfully, she says, that same year, her home state of West Virginia opted in to the 2010 Affordable Care Act’s Medicaid-coverage expansion, and she qualified. Over the next few years, as bad news kept rolling in, ACA protections continued to keep Stuart’s family afloat. When Stuart was diagnosed ...
Source: TIME: Health - March 19, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news

Clinical Impact of AF in Patients With Pulmonary Embolism Clinical Impact of AF in Patients With Pulmonary Embolism
This study aimed to assess the prevalence of atrial fibrillation in patients with confirmed acute pulmonary embolism. How does AF impact complications and outcomes in these patients?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Outpatient Management of Low-risk Pulmonary Embolism Outpatient Management of Low-risk Pulmonary Embolism
A new trial adds to the growing evidence that outpatient treatment of selected low-risk patients with pulmonary embolism can be done safely and effectively.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

U.S. Emergency Departments Over-Test for Suspected PE U.S. Emergency Departments Over-Test for Suspected PE
Overuse of computerized tomographic pulmonary angiography (CTPA) to rule out pulmonary embolism (PE) in U.S. emergency departments is costly and puts patients at risk for multiple adverse outcomes, a cross-sectional analysis suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 12, 2020 Category: Radiology Tags: Pulmonary Medicine News Source Type: news

Pulmonary Embolism
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 22, 2020 Category: General Medicine Source Type: news

Aidoc secures FDA clearance for AI stroke software
The U.S. Food and Drug Administration (FDA) has cleared Israeli artificial...Read more on AuntMinnie.comRelated Reading: Aidoc reports customer milestone Aidoc releases full AI software package for stroke care Aidoc nabs NY contract for AI software FDA clears Aidoc's AI for cervical spine fractures Aidoc scores FDA clearance for pulmonary embolism AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2020 Category: Radiology Source Type: news

FDA approves first generics of Eliquis
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (Source: World Pharma News)
Source: World Pharma News - December 26, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Fatal Embolism Infrequent, but Fuels Overdiagnosis Fatal Embolism Infrequent, but Fuels Overdiagnosis
In most cases clots are small and are not deadly, but in a controversy session on overdiagnosis, specialists agreed on one thing: Not all pulmonary embolisms are equal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2019 Category: Consumer Health News Tags: Radiology News Source Type: news

Aidoc reports customer milestone
Israeli artificial intelligence software developer Aidoc said that the Foundation...Read more on AuntMinnie.comRelated Reading: Aidoc releases full AI software package for stroke care Aidoc nabs NY contract for AI software FDA clears Aidoc's AI for cervical spine fractures Aidoc scores FDA clearance for pulmonary embolism AI Aidoc raises $27M in funding round (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2019 Category: Radiology Source Type: news

& #7429;-dimer Test Adjusted to Clinical Probability IDs Low Risk for PE
TUESDAY, Dec. 3, 2019 -- Low clinical pretest probability (C-PTP) and a ᴅ-dimer of less than 1,000 ng/mL identify patients with a low risk for pulmonary embolism, according to a study published in the Nov. 28 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 3, 2019 Category: Pharmaceuticals Source Type: news

What Causes Respiratory Failure?
Discussion The respiratory system is a complex system. The upper airways must remain patient. The lower airways must interface with the vascular system. The musculoskeletal system must provide mechanical function and the central nervous system must provide overall control. Respiratory failure occurs when the overall system cannot support the body’s necessarily ventilation, oxygenation or both. Children are at higher risk of respiratory failure. They have few intrinsic lung parenchyma problems, but have very small airways that increase the airflow resistance by themselves but then have to contend with problems such as...
Source: PediatricEducation.org - December 2, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

MRI contrast ferumoxytol causes very few side effects
Could ferumoxytol replace gadolinium-based contrast agents for some MRI scans?...Read more on AuntMinnie.comRelated Reading: Research road map drives inquiry into gadolinium's effects MRA tops CTA for pulmonary embolism evaluation Is ferumoxytol the alternative to gadolinium MRI agents? MRI shows pancreatic inflammation in diabetics (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2019 Category: Radiology Source Type: news

Risk of venous thromboembolism after carbon  monoxide poisoning: a nationwide population-based study - Cho Y, Kang H, Oh J, Lim TH, Ryu J, Ko BS.
STUDY OBJECTIVE: Few studies have investigated the association between carbon monoxide (CO) poisoning and risk of venous thromboembolism. We aim to identify the risk of pulmonary embolism and deep venous thrombosis after CO poisoning. METHODS: We c... (Source: SafetyLit)
Source: SafetyLit - November 27, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Clinical Decision Rules for Evaluating Suspected Pulmonary Embolism Underused Clinical Decision Rules for Evaluating Suspected Pulmonary Embolism Underused
Algorithms that combine a clinical decision rule (CDR) and highly sensitive D-dimer are widely recommended for identifying patients in whom pulmonary embolism can be safely excluded without further studies, but these algorithms appear to be underused, according to a survey of practitioners in the Veterans Administration (VA) healthcare system.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 23, 2019 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Researchers create swarms of tiny robots to attack and remove blood clots
(University of Houston) Current treatments for pulmonary embolism rely on clot-busting medication, sometimes with a surgical procedure to alter the clot. However, both options have been linked to unintended adverse events for patients. Researchers from the University of Houston's Robotic Swarm Control Laboratory and Houston Methodist Hospital are working on an innovative solution. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 18, 2019 Category: International Medicine & Public Health Source Type: news

Reversed halo sign on chest CT linked to septic PE
The presence of a reversed halo sign on chest CT scans is indicative of septic...Read more on AuntMinnie.comRelated Reading: Hospital in DC to study how opioids affect fetal brains Imaging for substance use disorder increasing in ED Senate opioid bill includes provision for ultrasound treatment CT use for pulmonary embolism rises despite low yield Medical images reveal toll of opioid epidemic (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 4, 2019 Category: Radiology Source Type: news

Medical & Surgical Review Programme: Pulmonary Embolism Report 2019
This report presents the main findings of a review by the National Confidential Enquiry into Patient Outcome and Death on the quality of care provided to patients aged over 16 years with a new diagnosis of pulmonary embolism. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Pulmonary Embolism Risk May Be Elevated for Months After Surgery Pulmonary Embolism Risk May Be Elevated for Months After Surgery
The postoperative risk of pulmonary embolism may be elevated for at least three months after all types of surgery, a retrospective case-crossover study suggests.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 16, 2019 Category: Surgery Tags: Pulmonary Medicine News Source Type: news

Pulmonary Embolism Risk Elevated for More Than Six Weeks Postop
Findings based on six common surgery types in large French study (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 15, 2019 Category: Respiratory Medicine Tags: Cardiology, Gastroenterology, Gynecology, Oncology, Orthopedics, Pharmacy, Pulmonology, Surgery, Journal, Source Type: news

Pulmonary Embolism Risk Elevated for More Than Six Weeks Postop
TUESDAY, Oct. 15, 2019 -- The postoperative risk for pulmonary embolism extends more than six weeks for six types of surgery, according to a study published online Oct. 9 in JAMA Surgery. Alexandre Caron, M.D., from University Lille in France, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 15, 2019 Category: Pharmaceuticals Source Type: news

Risk of PE significantly raised well beyond six weeks post-surgery
Postoperative pulmonary embolism risk still elevated 7-12 weeks later, regardless of the type of procedure Related items fromOnMedica Prescribe higher dose opioids for shorter time after surgery Poor pain management - a major cause of opioid crisis Statin use after stroke not linked to bleeds Don ’t delay young children’s surgery for fear of GA harms Earlier thrombolysis improves stroke outcomes (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 10, 2019 Category: UK Health Source Type: news

What Are Pulmonary Embolism Risk Factors?
Discussion Pulmonary embolism (PE) is potentially life-threatening but fortunately rare event especially in the pediatric population. It was first described in children in 1861. PE is likely underreported because of minimal or non-specific clinical symptoms. The incidence is estimated at 0.05-4.2% with the 4.2% based on autopsy reports. It is probably also increasing as more central venous catheters (CVC) are used, and more children are surviving previously poor prognostic diseases. There is a bimodal distribution with cases
Source: PediatricEducation.org - September 23, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Aidoc releases full AI software package for stroke care
Israeli artificial intelligence (AI) software developer Aidoc has released...Read more on AuntMinnie.comRelated Reading: Aidoc nabs NY contract for AI software FDA clears Aidoc's AI for cervical spine fractures Aidoc scores FDA clearance for pulmonary embolism AI Aidoc raises $27M in funding round Aidoc partners with Nuance on AI validation process (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 19, 2019 Category: Radiology Source Type: news

ESC Offers Updated Guidance on Acute Pulmonary Embolism ESC Offers Updated Guidance on Acute Pulmonary Embolism
The guidelines recommend direct oral anticoagulants as first-line treatment for most patients after PE and take on specific problems and vulnerable patient groups.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 14, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ESC Guidelines Updated for Diagnosis, Treatment of PE
WEDNESDAY, Sept. 4, 2019 -- In guidelines developed by the European Society of Cardiology, in collaboration with the European Respiratory Society, updated recommendations are presented for the management of patients with acute pulmonary embolism... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 4, 2019 Category: Pharmaceuticals Source Type: news

International Prehospital Medicine Institute Literature Review, September 2019
Logo courtesy International Prehospital Medicine Institute   Vol. 1.12 1.       Prehospital administration of tranexamic acid in trauma patients: A 1:1 matched comparative study from a level 1 trauma center. El-Mentar A, Sathian B, Wahlen BM, et al. Am J Em Med. Published on-line April 30, 2019. https://doi.org/10.1016/j.ajem.2019.04.051. 2.       Prehospital Blood Product Administration Opportunities in Ground Transport ALS EMS –A Descriptive Study. Mix, F; Zielinski, M; Myers, L; et al. Prehosp Disaster Med, 2018;33(3):230-236. 3.  &nbs...
Source: JEMS Patient Care - September 4, 2019 Category: Emergency Medicine Authors: International Prehospital Medicine Institute Tags: Training Exclusive Articles Patient Care Source Type: news

Personal Trauma Compels Blood Donor to Give Back
Orginally published on redcross.org.  I never really understood the importance of donating blood until I was the one needing it. In 2010, a pulmonary embolism nearly cost me my life. ... The post... {This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - August 28, 2019 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood Volunteers Amy Erickson blood donation blood donor platelets Red Cross volunteer transfusion Source Type: news

A Systematic Approach to Capnography Waveforms
Capnography was first proposed for use in the operating room in 1978 and has since become the standard of care for monitoring ventilation.1 Capnography is rapidly growing in use for intubated and non-intubated applications across hospital environments including the ICU, resuscitation, procedural sedation, and postoperative monitoring of patients receiving opioid analgesia. 1,2 When used appropriately, capnography has been cited as meaningful in providing key, often life- sustaining, information in dozens of different clinical applications. These range from common indications such as monitoring for apneas, hypoventilation, ...
Source: JEMS Patient Care - August 27, 2019 Category: Emergency Medicine Authors: Gina Farquharson, RRT-NPS, MBA, MS, CPPS Tags: Exclusive Articles Patient Care Cardiac & Resuscitation Source Type: news